Galapagos NV
GLPG
#4563
Rank
โ‚น189.74 B
Marketcap
โ‚น2,838
Share price
-0.57%
Change (1 day)
24.35%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น112.27 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are โ‚น112.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น110.58 B-23.06%
2023-12-31โ‚น143.73 B-26.67%
2022-12-31โ‚น196.01 B-8.8%
2021-12-31โ‚น214.93 B-21.59%
2020-12-31โ‚น274.12 B7.47%
2019-12-31โ‚น255.06 B1315.65%
2018-12-31โ‚น18.01 B-14.26%
2017-12-31โ‚น21.01 B-9.44%
2016-12-31โ‚น23.20 B311.98%
2015-12-31โ‚น5.63 B13.58%
2014-12-31โ‚น4.95 B-51.66%
2013-12-31โ‚น10.25 B21.18%
2012-12-31โ‚น8.46 B188.72%
2011-12-31โ‚น2.93 B8.22%
2010-12-31โ‚น2.70 B17%
2009-12-31โ‚น2.31 B-0.12%
2008-12-31โ‚น2.31 B-19.25%
2007-12-31โ‚น2.87 B-15.46%
2006-12-31โ‚น3.39 B211.84%
2005-12-31โ‚น1.08 B253.32%
2004-12-31โ‚น0.30 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
โ‚น6.152 T 5,379.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น10.199 T 8,984.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น5.931 T 5,182.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น12.262 T 10,821.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚น11.00 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น2.957 T 2,533.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น2.928 T 2,508.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น5.505 T 4,803.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น6.974 T 6,112.06%๐Ÿ‡บ๐Ÿ‡ธ USA